Innovative Discharge Process for Families with Pediatric Short Bowel Syndrome: A Prospective Nonrandomized Trial

Bram P Raphael1,2, Maria Jorina3, Mary Gallotto1,2

  • 1Home Parenteral Nutrition Program, Boston Children's Hospital, Boston, Massachusetts, USA.

Insights

A hands-on training course for home parenteral nutrition (HPN) in children with short bowel syndrome (SBS) did not significantly reduce post-discharge complications or readmissions in this pilot study.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Nutrition
  • Surgical Outcomes

Background:

  • Home parenteral nutrition (HPN) is crucial for children with short bowel syndrome (SBS) but often leads to complications.
  • Effective predischarge training is essential to mitigate risks associated with HPN therapy.

Purpose of the Study:

  • To evaluate a predischarge, hands-on HPN training course for pediatric SBS patients.
  • To assess the impact of this training on reducing hospital readmissions and other post-discharge complications.

Main Methods:

  • A prospective, nonrandomized controlled study involved children under 18 with SBS requiring HPN.
  • An intervention group received 24-hour hands-on HPN training, while the control group received standard education.
  • Data on post-discharge events were collected and compared between groups.

Main Results:

  • Nine children were in the intervention group and 12 in the control group; all experienced at least one HPN-related issue (47 total).
  • No significant difference in 30-day post-discharge events was found between the intervention and control groups.
  • Increased length of stay was associated with higher odds of emergency department visits and readmissions.

Conclusions:

  • The pilot hands-on HPN training intervention did not significantly decrease post-discharge complications in pediatric SBS patients.
  • Further refinement of HPN discharge processes and the establishment of quality benchmarks are necessary.
  • Additional research is needed to improve HPN management and patient outcomes.
Abstract

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.1K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Gene Families01:57

Gene Families

3.9K
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.2K
Protein Families02:47

Protein Families

4.5K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
889